JMPWA
ZSAN

JP Morgan Private Wealth Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-400
Closed -$7K – 2103
2021
Q4 		$7K Sell
400
-149
-27% -$3.15K ﹤0.01% 1982
2021
Q3 		$14K Hold
549
– – ﹤0.01% 1932
2021
Q2 		$18K Buy
+549
New +$17.7K ﹤0.01% 1892
2018
Q3 		– Sell
-1,986
Closed -$284K – 1631
2018
Q2 		$284K Buy
+1,986
New +$299K ﹤0.01% 1229
2017
Q4 		– Sell
-257
Closed -$148K – 1338
2017
Q3 		$148K Buy
257
+33
+15% +$24.2K ﹤0.01% 1179
2017
Q2 		$221K Buy
224
+133
+146% +$137K ﹤0.01% 1119
2017
Q1 		$121K Buy
+91
New +$110K ﹤0.01% 1288

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ZSAN Position: Q1 2022 in Review

JP Morgan Private Wealth Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q1 2022, closing a stake of 400 shares — an estimated $7K sold.

JP Morgan Private Wealth Advisors first reported a position in ZSAN in Q1 2017 and held it in 7 quarters. The position peaked at $284K in Q2 2018. 30 funds tracked by Wall St. Rank hold ZSAN as of Q1 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Zosano Pharma Corporation position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 400 Zosano Pharma Corporation shares in Q1 2022, an estimated $7K.
  • JP Morgan Private Wealth Advisors first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 7 quarters.
  • JP Morgan Private Wealth Advisors's Zosano Pharma Corporation position peaked at $284K in Q2 2018.
  • 30 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.